This inventor holds 1 USPTO granted patent and 9 published patent applications and 1 EPO patent. Top assignee: Orion Genomics LLC. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Joseph Bedell: Innovator in Cancer Diagnosis
Introduction
Joseph Bedell is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of cancer diagnosis through his innovative work. His research focuses on gene methylation, which plays a crucial role in identifying cancer biomarkers.
Latest Patents
Joseph Bedell holds a patent for his invention titled "Gene methylation in cancer diagnosis." This patent provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and those with cancer. The invention also outlines methods for identifying these differentially methylated DNA biomarker sequences, which can be utilized in detecting and diagnosing cancer.
Career Highlights
Joseph Bedell is associated with Orion Genomics LLC, a company dedicated to advancing genomic technologies. His work at Orion Genomics has allowed him to explore the intersection of genetics and cancer research, leading to groundbreaking advancements in diagnostic methods.
Collaborations
Joseph has collaborated with notable colleagues, including Jared Ordway and Jeffrey A. Jeddeloh. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of cancer diagnostics.
Conclusion
Joseph Bedell's contributions to cancer diagnosis through his patented invention highlight the importance of genetic research in medical advancements. His work continues to pave the way for improved diagnostic methods that can ultimately save lives.